Johns Hopkins Rheumatology

Home / RheumTV / Dr. Erika Darrah on How Biomarkers Reveal Early Disease Mechanisms

Dr. Erika Darrah on How Biomarkers Reveal Early Disease Mechanisms

By

Dr. Darrah has identified a unique subset of patients with Rheumatoid Arthritis at the molecular level. Her progress in the laboratory has improved disease monitoring and selection of effective therapies for RA patients.

Abstract Link

Autoantibodies to Peptidylarginine Deiminase 2 Protect Against Radiographic Progression in Patients with Rheumatoid Arthritis

Dr. Darrah has identified a unique subset of patients with Rheumatoid Arthritis at the molecular level. Her progress in the laboratory has improved disease monitoring and selection of effective therapies for RA patients.
Abstract Link
Autoantibodies to Peptidylarginine Deiminase 2 Protect Against Radiographic Progression in Patients with Rheumatoid Arthritis

Johns Hopkins Rheumatology

The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.